Stoke Therapeutics, Inc. (STOK)
36.23
+1.94
(+5.66%)
USD |
NASDAQ |
Feb 23, 16:00
36.40
+0.17
(+0.47%)
After-Hours: 06:52
Stoke Therapeutics Research and Development Expense (Quarterly) : 37.25M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Insmed, Inc. | 254.91M |
| Pfizer Inc. | 3.206B |
| Mirum Pharmaceuticals, Inc. | 42.90M |
| Moderna, Inc. | 708.00M |